Moreover, current methods of diagnosing allograft dysfunction are inadequate for detecting the significant organ damage that occurs prior to the establishment of clinical manifestations. The development of assays or novel technologies that will allow detection of allograft dysfunction/rejection, monitor responses to therapy, and predict long-term outcomes is vital for the success of transplantation.